IBDEI30M ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50548,1,4,0)
 ;;=4^L98.3
 ;;^UTILITY(U,$J,358.3,50548,2)
 ;;=^5009576
 ;;^UTILITY(U,$J,358.3,50549,0)
 ;;=L40.1^^219^2455^18
 ;;^UTILITY(U,$J,358.3,50549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50549,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,50549,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,50549,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,50550,0)
 ;;=L40.4^^219^2455^12
 ;;^UTILITY(U,$J,358.3,50550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50550,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,50550,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,50550,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,50551,0)
 ;;=L24.9^^219^2455^13
 ;;^UTILITY(U,$J,358.3,50551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50551,1,3,0)
 ;;=3^Irritant Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,50551,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,50551,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,50552,0)
 ;;=L30.0^^219^2455^14
 ;;^UTILITY(U,$J,358.3,50552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50552,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,50552,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,50552,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,50553,0)
 ;;=L40.8^^219^2455^15
 ;;^UTILITY(U,$J,358.3,50553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50553,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,50553,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,50553,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,50554,0)
 ;;=L30.8^^219^2455^9
 ;;^UTILITY(U,$J,358.3,50554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50554,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,50554,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,50554,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,50555,0)
 ;;=L40.0^^219^2455^16
 ;;^UTILITY(U,$J,358.3,50555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50555,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,50555,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,50555,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,50556,0)
 ;;=L40.9^^219^2455^17
 ;;^UTILITY(U,$J,358.3,50556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50556,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,50556,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,50556,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,50557,0)
 ;;=L40.3^^219^2455^19
 ;;^UTILITY(U,$J,358.3,50557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50557,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,50557,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,50557,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,50558,0)
 ;;=R21.^^219^2455^20
 ;;^UTILITY(U,$J,358.3,50558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50558,1,3,0)
 ;;=3^Rash/Oth Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,50558,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,50558,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,50559,0)
 ;;=L25.9^^219^2455^6
 ;;^UTILITY(U,$J,358.3,50559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50559,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,50559,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,50559,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,50560,0)
 ;;=M34.89^^219^2456^22
 ;;^UTILITY(U,$J,358.3,50560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50560,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,50560,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,50560,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,50561,0)
 ;;=M34.0^^219^2456^20
 ;;^UTILITY(U,$J,358.3,50561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50561,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,50561,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,50561,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,50562,0)
 ;;=F03.90^^219^2456^14
